MF is an ideal neoplasm to evaluate such therapeutic agents because it is characterized by sustained secretion of TGF-β, which contributes not only to BM fibrosis but also to the depletion of the pool of normal HSCs. This evidence concerns the gene TGFB1 and neoplasm.